IL10 and B-cell chronic lymphocytic leukemia: High amounts of IL-10 in sera of diffuse large B-cell lymphoma (DLBCL) (80), CLL (149), glioma (150), and cutaneous T cell lymphoma (151) patients are considered as a marker of unfavorable prognosis.